These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 5002520)

  • 21. Mycobacterial virulence. Virulent strains of Mycobacteria tuberculosis have faster in vivo doubling times and are better equipped to resist growth-inhibiting functions of macrophages in the presence and absence of specific immunity.
    North RJ; Izzo AA
    J Exp Med; 1993 Jun; 177(6):1723-33. PubMed ID: 8496688
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Repeated Aerosolized-Boosting with Gamma-Irradiated Mycobacterium bovis BCG Confers Improved Pulmonary Protection against the Hypervirulent Mycobacterium tuberculosis Strain HN878 in Mice.
    Cha SB; Kim WS; Kim JS; Kim H; Kwon KW; Han SJ; Eum SY; Cho SN; Shin SJ
    PLoS One; 2015; 10(10):e0141577. PubMed ID: 26509812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence inconsistent with a role for the Bcg gene (Nramp1) in resistance of mice to infection with virulent Mycobacterium tuberculosis.
    Medina E; North RJ
    J Exp Med; 1996 Mar; 183(3):1045-51. PubMed ID: 8642246
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distribution of mycobacteria grown in vivo in the organs of intravenously infected mice.
    Collins FM; Montalbine V
    Am Rev Respir Dis; 1976 Mar; 113(3):281-6. PubMed ID: 816236
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant BCG Tokyo (Ag85A) protects cynomolgus monkeys (Macaca fascicularis) infected with H37Rv Mycobacterium tuberculosis.
    Sugawara I; Li Z; Sun L; Udagawa T; Taniyama T
    Tuberculosis (Edinb); 2007 Nov; 87(6):518-25. PubMed ID: 17720625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of cultural conditions on the distribution of Mycobacterium tuberculosis in the spleens and lungs of specific pathogen-free mice.
    Collins FM; Wayne LG; v Montalbine
    Am Rev Respir Dis; 1974 Aug; 110(2):147-56. PubMed ID: 4278310
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunogenicity and protection induced by Mycobacterium tuberculosis mce-2 and mce-3 mutants in a Balb/c mouse model of progressive pulmonary tuberculosis.
    Aguilar LD; Infante E; Bianco MV; Cataldi A; Bigi F; Pando RH
    Vaccine; 2006 Mar; 24(13):2333-42. PubMed ID: 16388878
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The BCGΔBCG1419c strain, which produces more pellicle in vitro, improves control of chronic tuberculosis in vivo.
    Pedroza-Roldán C; Guapillo C; Barrios-Payán J; Mata-Espinosa D; Aceves-Sánchez Mde J; Marquina-Castillo B; Hernández-Pando R; Flores-Valdez MA
    Vaccine; 2016 Sep; 34(40):4763-70. PubMed ID: 27546876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lactoferrin augments BCG vaccine efficacy to generate T helper response and subsequent protection against challenge with virulent Mycobacterium tuberculosis.
    Hwang SA; Kruzel ML; Actor JK
    Int Immunopharmacol; 2005 Mar; 5(3):591-9. PubMed ID: 15683854
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced effect of BCG vaccine against pulmonary Mycobacterium tuberculosis infection in mice with lung Th17 response to mycobacterial heparin-binding hemagglutinin adhesin antigen.
    Fukui M; Shinjo K; Umemura M; Shigeno S; Harakuni T; Arakawa T; Matsuzaki G
    Microbiol Immunol; 2015 Dec; 59(12):735-43. PubMed ID: 26577130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of vaccines in the EU TB Vaccine Cluster using a guinea pig aerosol infection model of tuberculosis.
    Williams A; Hatch GJ; Clark SO; Gooch KE; Hatch KA; Hall GA; Huygen K; Ottenhoff TH; Franken KL; Andersen P; Doherty TM; Kaufmann SH; Grode L; Seiler P; Martin C; Gicquel B; Cole ST; Brodin P; Pym AS; Dalemans W; Cohen J; Lobet Y; Goonetilleke N; McShane H; Hill A; Parish T; Smith D; Stoker NG; Lowrie DB; Källenius G; Svenson S; Pawlowski A; Blake K; Marsh PD
    Tuberculosis (Edinb); 2005; 85(1-2):29-38. PubMed ID: 15687025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunization with Single Oral Dose of Alginate-Encapsulated BCG Elicits Effective and Long-Lasting Mucosal Immune Responses.
    Hosseini M; Dobakhti F; Pakzad SR; Ajdary S
    Scand J Immunol; 2015 Dec; 82(6):489-97. PubMed ID: 26286252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A study of the protective effect of the DNA vaccine encoding tubercle antigen 85B with MPT64 in mice challenged with Mycobacterium tuberculosis].
    Luo XD; Zhu DY; Chen Q; Jiang Y; Jiang S; Yang C
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Sep; 27(9):611-6. PubMed ID: 15498274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV-1 Tat protein vaccination in mice infected with Mycobacterium tuberculosis is safe, immunogenic and reduces bacterial lung pathology.
    Cafaro A; Piccaro G; Altavilla G; Gigantino V; Matarese G; Olivieri E; Ferrantelli F; Ensoli B; Palma C
    BMC Infect Dis; 2016 Aug; 16(1):442. PubMed ID: 27549342
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo electroporation of a codon-optimized BER
    Tang J; Cai Y; Liang J; Tan Z; Tang X; Zhang C; Cheng L; Zhou J; Wang H; Yam WC; Chen X; Wang H; Chen Z
    Tuberculosis (Edinb); 2018 Dec; 113():65-75. PubMed ID: 30514515
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resistance of high and low antibody responder lines of mice to the growth of avirulent (BCG) and virulent (H37Rv) strains of mycobacteria.
    Gheorghiu M; Mouton D; Lecoeur H; Lagranderie M; Mevel JC; Biozzi G
    Clin Exp Immunol; 1985 Jan; 59(1):177-84. PubMed ID: 3882283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Schistosoma mansoni infection reduces the protective efficacy of BCG vaccination against virulent Mycobacterium tuberculosis.
    Elias D; Akuffo H; Pawlowski A; Haile M; Schön T; Britton S
    Vaccine; 2005 Feb; 23(11):1326-34. PubMed ID: 15661380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Ag85B protein of the BCG vaccine facilitates macrophage uptake but is dispensable for protection against aerosol Mycobacterium tuberculosis infection.
    Prendergast KA; Counoupas C; Leotta L; Eto C; Bitter W; Winter N; Triccas JA
    Vaccine; 2016 May; 34(23):2608-15. PubMed ID: 27060378
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A new tool for tuberculosis vaccine screening: Ex vivo Mycobacterial Growth Inhibition Assay indicates BCG-mediated protection in a murine model of tuberculosis.
    Zelmer A; Tanner R; Stylianou E; Damelang T; Morris S; Izzo A; Williams A; Sharpe S; Pepponi I; Walker B; Hokey DA; McShane H; Brennan M; Fletcher H
    BMC Infect Dis; 2016 Aug; 16():412. PubMed ID: 27519524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.